Title of article - Atrial fibrillation in patients with diabetes: molecular mechanisms and therapeutic perspectives.
Abstract
Atrial fibrillation (AF) remains the most frequent sustained cardiac arrhythmia worldwide and its incidence increases with ageing, cardiovascular risk factors and comorbidities. Prevalence of diabetes mellitus (DM) is growing fast and is assuming pandemic proportions mostly due to overnutrition and sedentary habits. Experimental and clinical evidences suggest that DM and AF are strongly interconnected. The present review addresses in detail new molecular pathways implicated in the etiology of AF and their relevance for mechanism-based therapeutic strategies in this setting. Advances in risk stratification, drug therapy (i.e., novel anticoagulants) and catheter ablation are also described.
CLICK HERE for Full article Click button above to go to original article link with complete article details for Atrial fibrillation in patients with diabetes: molecular mechanisms and therapeutic perspectives.
Please CLICK HERE to discuss with us on facebook about this article.
Click below for Details of research Institute
1 Arrhythmia Unit, Department of Cardiology, Misericordia Hospital, Grosseto, Italy ; 2 Arrhythmia Unit, Department of Cardiology, OLV Hospital, Aalst, Belgium ; 3 Department of Cardiology, Misericordia Hospital, Grosseto, Italy ; 4 Department of Cardiovascular Medicine, University Hospital, Münster, Germany.
Details of Journal for Atrial fibrillation in patients with diabetes: molecular mechanisms and therapeutic perspectives.
Journal Title - Cardiovascular diagnosis and therapy
ISSN - 2223-3652
Volume - 5
Issue - 5
Publish date - 2015-Oct
Language - eng
Country - China (Republic : 1949- )
No comments:
Post a Comment